Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO Post author:Sam Post published:November 13, 2017 Post category:BioPharma Denali plans to make a $100M IPO under the symbol DNLI. Source: BioSpace You Might Also Like Rubius Therapeutics Raises $100 Million in Crossover Financing February 28, 2018 Bay Area's IMPAX Labs Surges on Merger Buzz September 21, 2017 FDA Shuts Down Addiction Study After Monkey Deaths January 28, 2018
